U nderstanding the nature of medication errors and their influencing factors is an important step in building systems which optimize patient care and safety. Although patient safety will always remain a complex issue, and require constant vigilance, several factors and influences have already been identified in an effort to create safer health care systems. One of the nationally recognized factors is the standardization of the methods used to communicate drug orders and other drug information-particularly in health care institutions. The communication of drug orders impacts all parts of the hospital patient stay, from admission to discharge. The use of standardized drug ordering has been associated with a variety of benefits, including but not limited to improvements in patient outcomes, 1-3 completeness of prescriptions, 4 reduced drug costs, 3, 5 and decreased medication errors. 6, 7 With the advent of technology, standardized drug prescribing comes in various forms, from preprinted hard copy to electronic format (eg, computerized physician order entry [CPOE], personal digital assistant [PDA]). Regardless of the presentation, the purpose of standardization in drug prescribing remains the same-to promote rational therapy while minimizing the risk for error.
Hospital Pharmacy is pleased to announce a new feature designed to provide examples of standardized drug prescribing and a forum for discussion. The intent is to share successful and effective cases of standardized prescribing. An example will be published every other month along with responses to the following questions:
1) What was the goal and purpose of the form (example: "This form was developed to address several medication safety issues in pediatric patients being treated with critical care agents, specifically surrounding concentration issues. The form was used to reduce delay in delivery time, maximize the use of commercially available products, and meet the JCAHO goal of using a limited number of standard concentrations.")?
2) Who was involved in the development and implementation of the form?
3) How was the form used and by who (eg, paper, computer screen, digital, etc)? 4) What benefits were realized from the use of the form? (eg, safety issues) 5) Were there any unforeseen problems with the form, and would you make any further mod-ifications based on experience (eg, include both brand and generic names on the form)?
Readers are encouraged to summit their examples with responses to the above questions to jallen@drugfacts.com.
